Please ensure Javascript is enabled for purposes of website accessibility

Stock Market Today: Lyft Goes Public

By Jim Crumly – Updated Apr 17, 2019 at 12:17PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Elsewhere, the merger between Bristol-Myers Squibb and Celgene got some votes of confidence.

Stocks ended their best quarter in nearly a decade on a positive note Friday after a key measure of inflation came in below expectations. The Dow Jones Industrial Average (^DJI -1.71%) has risen 10.9% in 2019 and the S&P 500 (^GSPC -1.51%) is up 12.9%.

Today's stock market

Index Percentage Change Point Change
Dow 0.82% 211.22
S&P 500 0.67% 18.96

Data source: Yahoo! Finance.

As for individual stocks, Lyft (LYFT -2.30%) made its debut as a public company today, and the merger between Bristol-Myers Squibb (BMY -0.86%) and Celgene (CELG) got some votes of confidence.

Bull figurine and rising stock graphs.

Image source: Getty Images.

Lyft gets off to a strong start

Shares of ridesharing specialist Lyft started trading today in one of the year's most anticipated initial public offerings. The stock rose 8.7% over the $72 offering price to end the session at $78.29. 

Lyft offered 32,500,000 shares of common stock, plus an option to the underwriters for an additional 4,875,000 shares, and raised over $2.4 billion for the company. After the close today, the company is valued at over $27 billion.

Lyft took in $2.16 billion in revenue in 2018, more than twice as much as in the year before, but lost $911 million, or $3.83 per pro forma share. Active riders in Q4 2018 rose 48% to 18.6 million and revenue per rider grew 32% to $36.04.

The market is excited about Lyft's rapid growth. The company appears to be on a path to profitability, but investors are left to ponder whether Lyft has a competitive advantage over Uber, whose own IPO could be coming soon, and whether the fundamentals support such a hefty valuation.

Check out the latest earnings call transcripts for the companies we cover.

Celgene's merger with Bristol-Myers Squibb just got more certain

A successful completion of the merger between Bristol-Myers Squibb and Celgene is looking more likely after independent proxy advisory firms Institutional Shareholder Services and Glass Lewis & Co. recommended that shareholders vote in favor of the deal. Shares of Celgene rose 7.9% to $94.34 on the news and those of Bristol-Myers fell 0.3% to $47.71.

Bristol-Myers and Celgene made headlines the first week of 2019 when they announced the cash-and-stock transaction worth $74 billion. The offer is $50 in cash and one share of Bristol-Myers for each Celgene share, as well a contingent value right worth $9 if three therapies in development are approved by set deadlines.

The deal was opposed by activist fund Starboard Value, and doubt about whether shareholders would approve the merger had resulted in Celgene's stock selling at a sizable discount to the offering price. Starboard withdrew its opposition in a press release today.

Even with the proxy service recommendations, the merger isn't completely certain yet. Earlier this week, the companies disclosed that the U.S. Federal Trade Commission is reviewing their pipelines and marketed products for psoriasis. But given that Celgene is now trading within 4% of the offering price, the market finally seems convinced that the deal will go through.

Jim Crumly owns shares of Celgene. The Motley Fool owns shares of and recommends Celgene. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Bristol Myers Squibb Company Stock Quote
Bristol Myers Squibb Company
$71.09 (-0.86%) $0.62
Celgene Corporation Stock Quote
Celgene Corporation
Lyft, Inc. Stock Quote
Lyft, Inc.
$13.17 (-2.30%) $0.31
Dow Jones Industrial Average (Price Return) Stock Quote
Dow Jones Industrial Average (Price Return)
$28,725.51 (-1.71%) $-500.10
S&P 500 Index - Price Return (USD) Stock Quote
S&P 500 Index - Price Return (USD)
$3,585.62 (-1.51%) $-54.85

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/02/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.